PEOPLE - Response Biomedical makes appointments:
This article was originally published in Clinica
Diagnostic tests manufacturer Response Biomedical (Vancouver, Canada) has made two key appointments. Sidney Braginsky, former president of Olympus America, has been elected to the board of directors. Rob Pilz has been appointed CFO and vice-president of finance. Mr Pilz previously served as CFO for a two-year term, but left in 2003.
You may also be interested in...
Akero’s FGF21 analog yields 63%-72% relative hepatic fat reduction in Phase IIa study; the company awaits biopsy data hoping to see a fibrotic benefit. Also, Genfit says COVID-19 pandemic should not significantly delay its Phase III NASH readout.
US Vice President Mike Pence and Medicare administrator Seema Verma want academic and university hospital laboratories to send their de-identified COVID-19 test data results, daily, to the Department of Health and Human Services. Commercial and private labs are exempt from the request, as they already share their coronavirus test results with the government.
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.